These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8498292)

  • 1. Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute myocardial infarction.
    Crea F; Davies G; Crake T; Gaspardone A; Galassi A; Kaski JC; Maseri A
    Am Heart J; 1993 Jun; 125(6):1547-52. PubMed ID: 8498292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Komjathy SF; Poulton J; Stafford JL; Godard J
    Circulation; 1994 Jan; 89(1):361-5. PubMed ID: 8281671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological characteristics of culprit atheromatic plaque are associated with coronary flow after thrombolytic therapy: new implications of optical coherence tomography from a multicenter study.
    Toutouzas K; Tsiamis E; Karanasos A; Drakopoulou M; Synetos A; Tsioufis C; Tousoulis D; Davlouros P; Alexopoulos D; Bouki K; Apostolou T; Stefanadis C
    JACC Cardiovasc Interv; 2010 May; 3(5):507-14. PubMed ID: 20488407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual coronary stenoses and calculated transstenotic gradients after intravenous streptokinase versus tissue plasminogen activator.
    Kimball BP; Bui S; Ling A; Dafopoulos N
    Am Heart J; 1992 Jan; 123(1):7-14. PubMed ID: 1729852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.
    Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA
    Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial.
    Mertens P; Maes A; Nuyts J; Belmans A; Desmet W; Esplugas E; Charlier F; Figueras J; Sambuceti G; Schwaiger M; Mortelmans L; Van de Werf F;
    Am Heart J; 2006 Jul; 152(1):125.e1-8. PubMed ID: 16824841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET perfusion and vasodilator function after angioplasty for acute myocardial infarction.
    Stewart RE; Miller DD; Bowers TR; McCullough PA; Ponto RA; Grines CL; O'Neill WW; Juni JE; Safian RD
    J Nucl Med; 1997 May; 38(5):770-7. PubMed ID: 9170444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion.
    Rebello SS; Huang J; Saito K; Saucedo JF; Bates ER; Lucchesi BR
    Eur J Pharmacol; 1999 Jun; 374(3):399-410. PubMed ID: 10422784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-type plasminogen activator: intracoronary applications.
    Tiefenbrunn AJ
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):108-15. PubMed ID: 2106393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired coronary flow reserve immediately after coronary angioplasty in patients with acute myocardial infarction.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Yoshimura M; Muraoka Y
    Br Heart J; 1993 Apr; 69(4):288-92. PubMed ID: 8489858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up.
    Maes A; Van de Werf F; Nuyts J; Bormans G; Desmet W; Mortelmans L
    Circulation; 1995 Oct; 92(8):2072-8. PubMed ID: 7554184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of impaired coronary flow reserve after reperfusion in patients with acute myocardial infarction.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K
    Am J Cardiol; 1996 Nov; 78(10):1103-8. PubMed ID: 8914871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
    Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the preexistent coronary collateral circulation and successful intracoronary thrombolysis for acute myocardial infarction.
    Araie E; Fujita M; Ohno A; Ejiri M; Yamanishi K; Miwa K; Nakajima H; Sasayama S
    Am Heart J; 1992 Jun; 123(6):1452-5. PubMed ID: 1595523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.